Baobab (Adansonia digitata L.) Fruit Pulp in Nutritional Therapeutics: Mechanistic Insights, Clinical Evidence, and Future Research Priorities

The renewed interest in indigenous African foods reflects a shift towards traditional, nutrient-dense alternatives to address the burden of non-communicable diseases and micronutrient deficiencies. This review evaluates the evidence for proposed health benefits of baobab (Adansonia digitata L.) fruit pulp (BFP) across four domains: gut homeostasis, immune modulation, glycemic control, and iron bioavailability. The evidence base is predominantly preclinical. Tier 3 (in vitro) and Tier 2 (animal) studies suggest that BFP fibers (low-methoxylated homogalacturonan, xylogalacturonan, and possibly inulin and fructooligosaccharides) may exert prebiotic-like effects by selectively stimulating Bifidobacteriaceae and Lactobacilli, while BFP polyphenols and organic acids have been associated with enzyme inhibition and enhanced iron bioaccessibility, respectively. The methodological quality of these studies was not assessed. However, human evidence is scarce. Only six human intervention studies were identified, limited to glycemic response in healthy normoglycemic adults and one iron status trial in schoolchildren, which showed increased hemoglobin but no significant improvement in ferritin or soluble transferrin receptor. No human studies have examined gut microbiota modulation, immune outcomes, or effects in diabetic or pre-diabetic populations. Consequently, clinical efficacy has not been established, and BFP cannot currently be characterized as having confirmed prebiotic or therapeutic properties. The current evidence supports potential prebiotic and enzyme-inhibitory activity in preclinical models only. Evidence-based dietary recommendations require high-quality human intervention trials with clinically meaningful endpoints, standardization of BFP preparations, and systematic investigation of real-world dietary contexts. Future research should address these gaps to advance the evidence base for BFP. Practical barriers to translation, including sensory acceptance, product adulteration, and sustainable sourcing, are briefly considered.

Authors

Institutions

Publication Details

Journal
Foods
Published
2026-10-09
DOI
https://doi.org/10.3390/foods15203579
Primary Topic
African Botany and Ecology Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Baobab (Adansonia digitata L.) Fruit Pulp in Nutritional Therapeutics: Mechanistic Insights, Clinical Evidence, and Future Research Priorities

Adeyemi Oladapo Aremu, Trust Mukudzei Pfukwa, Olaniyi Amos Fawole, Mukhtar Iderawumi Abdulraheem
Foods
African Botany and Ecology Studies
article

Baobab (Adansonia digitata L.) Fruit Pulp in Nutritional Therapeutics: Mechanistic Insights, Clinical Evidence, and Future Research Priorities

Adeyemi Oladapo Aremu, Trust Mukudzei Pfukwa, Olaniyi Amos Fawole, Mukhtar Iderawumi Abdulraheem
article en

Abstract

The renewed interest in indigenous African foods reflects a shift towards traditional, nutrient-dense alternatives to address the burden of non-communicable diseases and micronutrient deficiencies. This review evaluates the evidence for proposed health benefits of baobab (Adansonia digitata L.) fruit pulp (BFP) across four domains: gut homeostasis, immune modulation, glycemic control, and iron bioavailability. The evidence base is predominantly preclinical. Tier 3 (in vitro) and Tier 2 (animal) studies suggest that BFP fibers (low-methoxylated homogalacturonan, xylogalacturonan, and possibly inulin and fructooligosaccharides) may exert prebiotic-like effects by selectively stimulating Bifidobacteriaceae and Lactobacilli, while BFP polyphenols and organic acids have been associated with enzyme inhibition and enhanced iron bioaccessibility, respectively. The methodological quality of these studies was not assessed. However, human evidence is scarce. Only six human intervention studies were identified, limited to glycemic response in healthy normoglycemic adults and one iron status trial in schoolchildren, which showed increased hemoglobin but no significant improvement in ferritin or soluble transferrin receptor. No human studies have examined gut microbiota modulation, immune outcomes, or effects in diabetic or pre-diabetic populations. Consequently, clinical efficacy has not been established, and BFP cannot currently be characterized as having confirmed prebiotic or therapeutic properties. The current evidence supports potential prebiotic and enzyme-inhibitory activity in preclinical models only. Evidence-based dietary recommendations require high-quality human intervention trials with clinically meaningful endpoints, standardization of BFP preparations, and systematic investigation of real-world dietary contexts. Future research should address these gaps to advance the evidence base for BFP. Practical barriers to translation, including sensory acceptance, product adulteration, and sustainable sourcing, are briefly considered.

FoodsVol. 15(20)
University of Johannesburg (ZA), North-West University (ZA)
Openalex Percentile: Top 8%
African Botany and Ecology Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.